Aromatase Inhibitors

Many breast tumours are dependent upon oestrogen for their development and continued growth. Over the last 25 years hormone therapy has progressed from the irreversible destruction of endocrine glands to the use of drugs that reversibly suppress oestrogen synthesis or action. The inhibition of oestr...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Furr, Barrington J.A (Editor)
Format: Electronic eBook
Language:English
Published: Basel : Birkhäuser Basel, 2006.
Series:Milestones in Drug Therapy MDT
Subjects:
Online Access:Full Text via HEAL-Link
Table of Contents:
  • Background and development of aromatase inhibitors
  • Aromatase inhibitors and models for breast cancer
  • Clinical pharmacology of aromatase inhibitors
  • Clinical studies with exemestane
  • Clinical studies with letrozole
  • Clinical studies with anastrozole
  • The third-generation aromatase inhibitors: a clinical overview
  • Lessons from the ArKO mouse
  • Possible additional therapeutic uses of aromatase inhibitors.